News

INDIANAPOLIS and LINCOLNSHIRE, Ill., April 22, 2024 – Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical industry.

Project Metrics INDUSTRY Pharmaceutical Manufacturing DIRECT JOBS 200 CAPITAL EXPENDITURE $250 million REAL ESTATE 15 acres, 200,000 square feet LOCATION Pleasant Prairie, Wisconsin “M7 did an excellent job communicating the Wisconsin value proposition, which factored importantly into our decision to site our new production operation in Pleasant